With the help of both T7 and the NGR peptide, T7/NGR-RBCSLNs could traverse the in vitro BBB and BBTB barriers (Figure 2B and 2C) and exhibited the highest accumulation in the brain tumor sites in glioma-bearing mice (Figure 2D). This evidence concerns the gene RTN4R and glioma.